Screener
Sarepta Therapeutics, Inc. SRPT Business Segments — Income Tax
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:IncomeTaxExpense.
The source filing: Sarepta Therapeutics, Inc.’s 10-K, filed March 2, 2026.
- Filed
- Mar 2, 2026, 7:02 AM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-084144
| Line item | For the Year Ended December 31, 2025 | For the Year Ended December 31, 2024 | For the Year Ended December 31, 2023 |
|---|---|---|---|
| Loss (gain) on strategic investments, net | 15,914 | 2,785 | (1,527) |
| Interest expense | 38,140 | 18,391 | 22,010 |
| Interest income | (30,763) | (30,635) | (36,257) |
| Income tax expense | 11,185 | 25,535 | 15,879 |
| Depreciation and amortization expense | 44,521 | 37,724 | 44,397 |
| Stock-based compensation expense | 123,396 | 184,300 | 182,514 |
| Gain from sale of Priority Review Voucher | — | — | (102,000) |
| Impairment of strategic investments | — | — | 30,321 |
Item 16. Form 10-K Summary.
FAQ
- What is Sarepta Therapeutics, Inc.'s business segments — income tax?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — income tax of $2.8M in Q4 2025.
- How has Sarepta Therapeutics, Inc.'s business segments — income tax changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — income tax decreased by 56.2% year-over-year, from $6.38M to $2.8M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — income tax?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — income tax has grown at a -6.1% compound annual growth rate (CAGR), from $13.53M to $11.19M.
- What does business segments — income tax mean?
- This metric represents the total provision for income taxes allocated to the specific business segment. It reflects the tax burden associated with the segment's operational earnings and jurisdictional tax obligations. Monitoring this helps investors understand the effective tax rate impact on the segment's bottom-line contribution.
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude